NCT02551380: Folinic Acid in Children With Autism Spectrum Disorders
- State
- State not given
- Phase
- Phase 2
- People
- 40 planned
- Started
- Oct 2015
- Primary completion
- Jan 2018
- Arms
- Treated
- Results
- None posted
- 16 Sep 2015: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 5 registered trials.
Also followed for narrower conditions: Asperger Syndrome, Autistic Disorder
Kind of treatment: Drug.
Also known as Folinoral, Folinic Acid.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.